0000899243-18-018430.txt : 20180627 0000899243-18-018430.hdr.sgml : 20180627 20180627183427 ACCESSION NUMBER: 0000899243-18-018430 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180627 FILED AS OF DATE: 20180627 DATE AS OF CHANGE: 20180627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Atlas Venture Fund VIII, L.P. CENTRAL INDEX KEY: 0001451626 FISCAL YEAR END: 1208 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38550 FILM NUMBER: 18922796 BUSINESS ADDRESS: STREET 1: 890 WINTER STREET STREET 2: SUITE 320 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-622-1700 MAIL ADDRESS: STREET 1: 890 WINTER STREET STREET 2: SUITE 320 CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Atlas Venture Associates VIII, L.P. CENTRAL INDEX KEY: 0001451625 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38550 FILM NUMBER: 18922797 BUSINESS ADDRESS: STREET 1: 890 WINTER STREET STREET 2: SUITE 320 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-622-1700 MAIL ADDRESS: STREET 1: 890 WINTER STREET STREET 2: SUITE 320 CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Atlas Venture Associates VIII, Inc. CENTRAL INDEX KEY: 0001451624 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38550 FILM NUMBER: 18922798 BUSINESS ADDRESS: STREET 1: 890 WINTER STREET STREET 2: SUITE 320 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-622-1700 MAIL ADDRESS: STREET 1: 890 WINTER STREET STREET 2: SUITE 320 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Translate Bio, Inc. CENTRAL INDEX KEY: 0001693415 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 611807780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-945-7361 MAIL ADDRESS: STREET 1: 29 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: RaNA Therapeutics, Inc. DATE OF NAME CHANGE: 20161228 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2018-06-27 0 0001693415 Translate Bio, Inc. TBIO 0001451626 Atlas Venture Fund VIII, L.P. 25 FIRST STREET, SUITE 303 CAMBRIDGE MA 02141 0 0 1 0 0001451625 Atlas Venture Associates VIII, L.P. 25 FIRST STREET, SUITE 303 CAMBRIDGE MA 02141 0 0 1 0 0001451624 Atlas Venture Associates VIII, Inc. 25 FIRST STREET, SUITE 303 CAMBRIDGE MA 02141 0 0 1 0 Common Stock 90000 D Series A Preferred Stock Common Stock 2326567 D Series B Preferred Stock Common Stock 1050891 D Series C Preferred Stock Common Stock 454550 D The Series A Preferred Stock is convertible into Common Stock on a 5.5555-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. The Series B Preferred Stock is convertible into Common Stock on a 5.5555-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. The Series C Preferred Stock is convertible into Common Stock on a 5.5555-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. These shares are held directly by Atlas Venture Fund VIII, L.P. ("Atlas Venture Fund VIII"). The general partner of Atlas Venture Fund VIII is Atlas Venture Associate VIII, L.P. ("AVA VIII LP"). Atlas Venture Associates VIII, Inc. ("AVA VIII INC") is the general partner of AVA VIII LP. Each of AVA VIII LP and AVA VIII INC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund VIII, except to the extent of its pecuniary interest therein, if any. This report shall not be deemed to be an admission that the reporting persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Atlas Venture Fund VIII, L.P., By: Atlas Venture Associates VIII, L.P., its general partner, By: Atlas Venture Associates VIII, Inc., its general partner, By: Frank Castellucci, General Counsel and Secretary /s/ Frank Castellucci 2018-06-27 Atlas Venture Associates VIII, L.P. By: Atlas Venture Associates VIII, Inc., its general partner, By: Frank Castellucci, General Counsel and Secretary /s/ Frank Castellucci 2018-06-27 Atlas Venture Associates VIII, Inc, By: Frank Castellucci, General Counsel and Secretary /s/ Frank Castellucci 2018-06-27